Natus Sensory Inc.

Natus Sensory Inc. is a global leader in sensory care, dedicated to supporting clinicians across the fields of hearing, balance, vision, and newborn care. The company's mission is to improve patient outcomes by providing healthcare professionals with advanced tools for accurate diagnoses and effective treatments, ultimately helping millions reconnect with the world through enhanced sensory capabilities and ensuring every baby receives the best possible start in life. Headquartered in Schaumburg, Illinois, USA, Natus Sensory operates with a global presence, serving clinicians in over 120 countries.

The company develops trusted solutions for assessment, screening, monitoring, and therapy, grounded in real-world clinical needs. Its comprehensive product portfolio includes solutions for adult hearing, vision, and vestibular assessment, such as audiological, otoneurologic, and vestibular instrumentation. Natus Sensory also provides products for pediatric hearing and vision screenings, jaundice management, and live video streaming for infants in neonatal intensive care units. Key product lines include the Newborn Care portfolio with brands like ALGO®, NicView®, and neoBLUE®, while its Hearing and Balance solutions are unified under the Otometrics brand, encompassing Madsen audiometers, Aurical fitting and verification systems, and ICS vestibular diagnostics.

Natus Sensory Inc. was formed as an independent company in January 2025, following the take-private acquisition of Natus Medical Incorporated by ARCHIMED in July 2022. Peter Reimer serves as the CEO. Recent strategic developments include the restoration of the Otometrics brand in April 2026 to unify its hearing and balance solutions, and several acquisitions in early 2026, such as TheraB Medical for neonatal phototherapy and Keriton for connected newborn care. The company also strengthened its executive team in April 2025 with key leadership appointments to drive innovation and expand its global impact.